Amanda Lacroix v. HHS - Meningococcal, transverse myelitis (2015)

Amanda Lacroix filed a petition on May 28, 2013, alleging that a meningococcal (Menactra) vaccination she received on December 3, 2011 caused her to develop transverse myelitis (TM) with resulting neurologic injuries and that she experienced the residual effects of this injury for more than six months. Respondent denied that the vaccine caused petitioner's transverse myelitis or any other injury.

Nonetheless, both parties agreed to a joint stipulation filed July 22, 2015 to settle the case. Special Master Dorsey found the stipulation reasonable and adopted it as the decision of the Court.

Petitioner's compensation included a lump sum of $250,000.00 for damages available under 42 U.S.C. § 300aa-15(a), along with an annuity to cover future costs. The parties subsequently agreed to attorneys' fees and costs of $46,000.00, payable jointly to petitioner and her counsel, Michael A.

Baseluos. Petitioner had not personally incurred any out-of-pocket litigation expenses.